GTBPVSSNYR• 28 Days (Normalized)
GTBP vs SNYR (GT Biopharma Inc. vs Synergy CHC Corp.)
Showing Closing Date Range from Aug 28 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+2266.67%
GT Biopharma Inc.
Normalized Baseline0.00%
SNYR Performance $0.03
+%
Synergy CHC Corp.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+2266.67 pts
GTBP outperforming by 2266.67 percentage points
GTBPSNYR
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP SNYR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | GTBP Price | GTBP Gain (%) | SNYR Price | SNYR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +2266.67% | $- | - | |
| Sep 22, 2026 | $- | $0.03 | -72.91% | - | |
| Sep 21, 2026 | $7.18 | +2293.33% | $0.04 | -60.19% | +2353.52% |
| Sep 18, 2026 | $7.16 | +2286.67% | $0.05 | -47.57% | +2334.24% |
| Sep 17, 2026 | $7.49 | +2396.67% | $0.09 | -12.14% | +2408.81% |
| Sep 16, 2026 | $7.81 | +2503.33% | $0.27 | +166.02% | +2337.31% |
| Sep 15, 2026 | $9.00 | +2900.00% | $0.08 | -20.39% | +2920.39% |
| Sep 14, 2026 | $11.63 | +3776.67% | $0.09 | -11.65% | +3788.32% |
| Sep 11, 2026 | $8.61 | +2770.00% | $0.10 | -1.94% | +2771.94% |
| Sep 10, 2026 | $6.18 | +1960.00% | $0.11 | +4.85% | +1955.15% |
| Sep 09, 2026 | $5.98 | +1893.33% | $0.08 | -19.42% | +1912.75% |
| Sep 08, 2026 | $- | $0.08 | -19.42% | - | |
| Sep 04, 2026 | $0.24 | -19.67% | $0.10 | +0.00% | -19.67% |
| Sep 03, 2026 | $0.25 | -16.00% | $0.11 | +6.80% | -22.80% |
| Sep 02, 2026 | $0.28 | -5.67% | $0.11 | +8.74% | -14.41% |
Page 1 of 2